Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: Implications for schizophrenia

Molecular and Cellular Neuroscience

Volumn 61, Issue , 2014, Pages 163-175

  Lin, Hong ^a   Hsu, Fu Chun ^a   Baumann, Bailey H ^a   Coulter, Douglas A ^a   Anderson, Stewart A ^a,b   Lynch, David R ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cortex; GABAergic; NMDA receptor; Parvalbumin; 7 nicotinic ACh receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; BUNGAROTOXIN RECEPTOR; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARVALBUMIN; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CHRNA7 PROTEIN, MOUSE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL CULTURE; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; GENE DELETION; IMMUNOREACTIVITY; INTERNEURON; MALE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SYNAPTOSOME; AGE; ANIMAL; ANIMAL EMBRYO; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INHIBITORY POSTSYNAPTIC POTENTIAL; MEMBRANE POTENTIAL; METABOLISM; NERVE CELL; NEWBORN; PHYSIOLOGY; TRANSGENIC MOUSE;

AGE FACTORS; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO, MAMMALIAN; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUTAMATE DECARBOXYLASE; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PARVALBUMINS; RECEPTORS, GABA-A;

EID: 84904256703     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.06.007     Document Type: Article

References (75)

1. Adams C.E., Stevens K.E. Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Front. Biosci. 2007, 12:4755-4772.
2. Adams C.E., Stitzel J.A., Collins A.C., Freedman R. Alpha7-nicotinic receptor expression and the anatomical organization of hippocampal interneurons. Brain Res. 2001, 922:180-190.
3. Adams C.E., Broide R.S., Chen Y., Winzer-Serhan U.H., Henderson T.A., Leslie F.M., Freedman R. Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation. Brain Res. Dev. Brain Res. 2002, 139:175-187.
4. Adams C.E., Yonchek J.C., Zheng L., Collins A.C., Stevens K.E. Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. Brain Res. 2008, 1194:138-145.
5. Adams C.E., Yonchek J.C., Schulz K.M., Graw S.L., Stitzel J., Teschke P.U., Stevens K.E. Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases. Neuroscience 2012, 207:274-282.
6. Ancin I., Cabranes J.A., Santos J.L., Sanchez-Morla E., Vazquez-Alvarez B., Rodriguez-Moya L., Pousada-Casal A., Fernandez C., Aparicio A., Barabash A. CHRNA7 haplotypes are associated with impaired attention in euthymic bipolar disorder. J. Affect. Disord. 2011, 133:340-345.
7. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., Quinlan E.M., Nakazawa K. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 2010, 13:76-83.
8. Breese C.R., Adams C., Logel J., Drebing C., Rollins Y., Barnhart M., Sullivan B., Demasters B.K., Freedman R., Leonard S. Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. J. Comp. Neurol. 1997, 387:385-398.
9. Brown K.L., Comalli D.M., De Biasi M., Woodruff-Pak D.S. Trace eyeblink conditioning is impaired in alpha7 but not in beta2 nicotinic acetylcholine receptor knockout mice. Front. Behav. Neurosci. 2010, 4:166.
10. Bruel-Jungerman E., Lucassen P.J., Francis F. Cholinergic influences on cortical development and adult neurogenesis. Behav. Brain Res. 2011, 221:379-388.
11. Cannon C.E., Puri V., Vivian J.A., Egbertson M.S., Eddins D., Uslaner J.M. The nicotinic alpha7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys. Neuropharmacology 2013, 64:191-196.
12. Carlen M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., Ruhlmann C., Jones S.R., Deisseroth K., Sheng M., Moore C.I., Tsai L.H. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol. Psychiatry 2012, 17:537-548.
13. Curley A.A., Lewis D.A. Cortical basket cell dysfunction in schizophrenia. J. Physiol. 2012, 590:715-724.
14. Dani J.A., Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 2007, 47:699-729.
15. Dong Y.N., Waxman E.A., Lynch D.R. Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J. Neurosci. 2004, 24:11035-11045.
16. Endris V., Hackmann K., Neuhann T.M., Grasshoff U., Bonin M., Haug U., Hahn G., Schallner J.C., Schrock E., Tinschert S., Rappold G., Moog U. Homozygous loss of CHRNA7 on chromosome 15q13.3 causes severe encephalopathy with seizures and hypotonia. Am. J. Med. Genet. A 2010, 152A:2908-2911.
17. Fernandes C., Hoyle E., Dempster E., Schalkwyk L.C., Collier D.A. Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav. 2006, 5:433-440.
18. Freedman R. Alpha7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia. Annu. Rev. Med. 2014, 65:245-261.
19. Freedman R., Goldowitz D. Studies on the hippocampal formation: from basic development to clinical applications: studies on schizophrenia. Prog. Neurobiol. 2010, 90:263-275.
20. Freedman R., Leonard S. Genetic linkage to schizophrenia at chromosome 15q14. Am. J. Med. Genet. 2001, 105:655-657.
21. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 1995, 38:22-33.
22. Freedman R., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:587-592.
23. Freedman R., Adams C.E., Leonard S. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J. Chem. Neuroanat. 2000, 20:299-306.
24. Fung S.J., Webster M.J., Sivagnanasundaram S., Duncan C., Elashoff M., Weickert C.S. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am. J. Psychiatry 2010, 167:1479-1488.
25. Gonzalez-Burgos G., Fish K.N., Lewis D.A. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast. 2011, 2011:723184.
26. Griguoli M., Cherubini E. Regulation of hippocampal inhibitory circuits by nicotinic acetylcholine receptors. J. Physiol. 2012, 590:655-666.
27. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., Gallop R.J., Arnold S.E. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 2006, 12:824-828.
28. Hajos N., Paulsen O. Network mechanisms of gamma oscillations in the CA3 region of the hippocampus. Neural Netw. 2009, 22:1113-1119.
29. Hajos M., Rogers B.N. Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia. Curr. Pharm. Des. 2010, 16:538-554.
30. Hancock M.L., Canetta S.E., Role L.W., Talmage D.A. Presynaptic type III neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons. J. Cell Biol. 2008, 181:511-521.
31. Helbig I., et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat. Genet. 2009, 41:160-162.
32. Hellier J.L., Arevalo N.L., Smith L., Xiong K.N., Restrepo D. Alpha7-nicotinic acetylcholine receptor: role in early odor learning preference in mice. PLoS One 2012, 7:e35251.
33. Hoftman G.D., Lewis D.A. Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr. Bull. 2011, 37:493-503.
34. Hoppman-Chaney N., Wain K., Seger P., Superneau D., Hodge J. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype. Clin. Genet. 2013, 83:345-351.
35. Inan M., Petros T.J., Anderson S.A. Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia. Neurobiol. Dis. 2013, 53:36-48.
36. Jiang Z., Cowell R.M., Nakazawa K. Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia. Front. Behav. Neurosci. 2013, 7:116.
37. Korotkova T., Fuchs E.C., Ponomarenko A., von Engelhardt J., Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68:557-569.
38. Le Magueresse C., Monyer H. GABAergic interneurons shape the functional maturation of the cortex. Neuron 2013, 77:388-405.
39. Le Magueresse C., Safiulina V., Changeux J.P., Cherubini E. Nicotinic modulation of network and synaptic transmission in the immature hippocampus investigated with genetically modified mice. J. Physiol. 2006, 576:533-546.
40. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 1996, 22:431-445.
41. Leonard S., Gault J., Hopkins J., Logel J., Vianzon R., Short M., Drebing C., Berger R., Venn D., Sirota P., Zerbe G., Olincy A., Ross R.G., Adler L.E., Freedman R. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry 2002, 59:1085-1096.
42. Lepichon J.B., Bittel D.C., Graf W.D., Yu S. A 15q13.3 homozygous microdeletion associated with a severe neurodevelopmental disorder suggests putative functions of the TRPM1, CHRNA7, and other homozygously deleted genes. Am. J. Med. Genet. A 2010, 152A:1300-1304.
43. Levin E.D., Petro A., Rezvani A.H., Pollard N., Christopher N.C., Strauss M., Avery J., Nicholson J., Rose J.E. Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav. Brain Res. 2009, 196:207-213.
44. Lewis D.A., Curley A.A., Glausier J.R., Volk D.W. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012, 35:57-67.
45. Liao J., DeWard S.J., Madan-Khetarpal S., Surti U., Hu J. A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features. Am. J. Med. Genet. A 2011, 155A:2795-2800.
46. Lin H., Vicini S., Hsu F.C., Doshi S., Takano H., Coulter D.A., Lynch D.R. Axonal alpha7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16661-16666.
47. Lin H., Hsu F.C., Baumann B.H., Coulter D.A., Lynch D.R. Cortical synaptic NMDA receptor deficits in alpha7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases. Neurobiol. Dis. 2014, 63:129-140.
48. Liu Z., Neff R.A., Berg D.K. Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. Science 2006, 314:1610-1613.
49. Lozada A.F., Wang X., Gounko N.V., Massey K.A., Duan J., Liu Z., Berg D.K. Glutamatergic synapse formation is promoted by alpha7-containing nicotinic acetylcholine receptors. J. Neurosci. 2012, 32:7651-7661.
50. Mathew S.V., Law A.J., Lipska B.K., Davila-Garcia M.I., Zamora E.D., Mitkus S.N., Vakkalanka R., Straub R.E., Weinberger D.R., Kleinman J.E., Hyde T.M. Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. Hum. Mol. Genet. 2007, 16:2921-2932.
51. McNally J.M., McCarley R.W., Brown R.E. Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations. Curr. Psychiatry Rep. 2013, 15:346.
52. Miller D.T., et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J. Med. Genet. 2009, 46:242-248.
53. Miwa J.M., Freedman R., Lester H.A. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 2011, 70:20-33.
54. Murakami K., Ishikawa Y., Sato F. Localization of alpha7 nicotinic acetylcholine receptor immunoreactivity on GABAergic interneurons in layers I-III of the rat retrosplenial granular cortex. Neuroscience 2013, 252:443-459.
55. Nakazawa K., Zsiros V., Jiang Z., Nakao K., Kolata S., Zhang S., Belforte J.E. GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 2012, 62:1574-1583.
56. Olincy A., Freedman R. Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the alpha7 nicotinic receptor. Handb. Exp. Pharmacol. 2012, 211-232.
57. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J.A., Patrick J.W., Beaudet A.L. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 1997, 17:9165-9171.
58. Ross R.G., Stevens K.E., Proctor W.R., Leonard S., Kisley M.A., Hunter S.K., Freedman R., Adams C.E. Research review: cholinergic mechanisms, early brain development, and risk for schizophrenia. J. Child Psychol. Psychiatry 2010, 51:535-549.
59. Rotaru D.C., Yoshino H., Lewis D.A., Ermentrout G.B., Gonzalez-Burgos G. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J. Neurosci. 2011, 31:142-156.
60. Sharp A.J., et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet. 2008, 40:322-328.
61. Shinawi M., Schaaf C.P., Bhatt S.S., Xia Z., Patel A., Cheung S.W., Lanpher B., Nagl S., Herding H.S., Nevinny-Stickel C., Immken L.L., Patel G.S., German J.R., Beaudet A.L., Stankiewicz P. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat. Genet. 2009, 41:1269-1271.
62. Sinkus M.L., Lee M.J., Gault J., Logel J., Short M., Freedman R., Christian S.L., Lyon J., Leonard S. A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res. 2009, 1291:1-11.
63. Song C., Murray T.A., Kimura R., Wakui M., Ellsworth K., Javedan S.P., Marxer-Miller S., Lukas R.J., Wu J. Role of alpha7-nicotinic acetylcholine receptors in tetanic stimulation-induced gamma oscillations in rat hippocampal slices. Neuropharmacology 2005, 48:869-880.
64. Spielmann M., Reichelt G., Hertzberg C., Trimborn M., Mundlos S., Horn D., Klopocki E. Homozygous deletion of chromosome 15q13.3 including CHRNA7 causes severe mental retardation, seizures, muscular hypotonia, and the loss of KLF13 and TRPM1 potentially cause macrocytosis and congenital retinal dysfunction in siblings. Eur. J. Med. Genet. 2011, 54:e441-e445.
65. Stevens K.E., Kem W.R., Mahnir V.M., Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl) 1998, 136:320-327.
66. Ting A.K., Chen Y., Wen L., Yin D.M., Shen C., Tao Y., Liu X., Xiong W.C., Mei L. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J. Neurosci. 2011, 31:15-25.
67. Tregellas J.R., Tanabe J., Rojas D.C., Shatti S., Olincy A., Johnson L., Martin L.F., Soti F., Kem W.R., Leonard S., Freedman R. Effects of an alpha7-nicotinic agonist on default network activity in schizophrenia. Biol. Psychiatry 2011, 69:7-11.
68. Volman V., Behrens M.M., Sejnowski T.J. Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity. J. Neurosci. 2011, 31:18137-18148.
69. Wallace T.L., Bertrand D. Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex. Biochem. Pharmacol. 2013, 85:1713-1720.
70. Wallace T.L., Porter R.H. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem. Pharmacol. 2011, 82:891-903.
71. Yasui D.H., Scoles H.A., Horike S., Meguro-Horike M., Dunaway K.W., Schroeder D.I., Lasalle J.M. 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum. Mol. Genet. 2011, 20:4311-4323.
72. Young J.W., Crawford N., Kelly J.S., Kerr L.E., Marston H.M., Spratt C., Finlayson K., Sharkey J. Impaired attention is central to the cognitive deficits observed in alpha7 deficient mice. Eur. Neuropsychopharmacol. 2007, 17:145-155.
73. Young J.W., Meves J.M., Tarantino I.S., Caldwell S., Geyer M.A. Delayed procedural learning in alpha7-nicotinic acetylcholine receptor knockout mice. Genes Brain Behav. 2011, 10:720-733.
74. Yu W.F., Guan Z.Z., Nordberg A. Postnatal upregulation of alpha4 and alpha3 nicotinic receptor subunits in the brain of alpha7 nicotinic receptor-deficient mice. Neuroscience 2007, 146:1618-1628.
75. Zhang L., Warren R.A. Muscarinic and nicotinic presynaptic modulation of EPSCs in the nucleus accumbens during postnatal development. J. Neurophysiol. 2002, 88:3315-3330.